Ali Arif Nasir 13D and 13G filings for Entero Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-10 9:30 pm Sale |
2025-06-06 | 13D | Entero Therapeutics, Inc. ENTO |
Ali Arif Nasir | 230,900 4.900% |
-20,000 (-7.97%) |
Filing |
| 2025-06-09 9:55 pm Purchase |
2025-06-02 | 13D | Entero Therapeutics, Inc. ENTO |
Ali Arif Nasir | 250,900 5.300% |
250,900 (New Position) |
Filing |